Cabalin CR Extended-Release Tablet 75 mg (Pregabalin)
Pregabalin 42mg
Tablet · Prescription medication
GL Pharm Tech Co., Ltd.
MFDS item code 202401115 · Approved 2024.05.07
Treatment of peripheral neuropathic pain in adults
This medication is used to effectively treat peripheral neuropathic pain in adults. It alleviates pain caused by nerve damage, thereby reducing the discomfort patients experience in their daily lives. It improves continuous pain to enhance quality of life. It safely supports the management of neuropathic pain and aids in the patient's recovery. This drug has a positive effect on the control of nerve-related pain.
1. This medicine is administered once daily after the evening meal. The tablet must be swallowed whole and must not be split, crushed, or chewed. Since this medicine is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function (see “2. Patients with Renal Impairment”). Adults: This medicine may be initiated at a dose of 1 tablet of 150 mg once daily. Based on the response and tolerability of each patient, the dose may be increased at weekly intervals to a maximum of 600 mg once daily. Discontinuation of treatment: Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually, with intervals of at least 1 week. 2. Patients with renal impairment This medicine (pregabalin 75mg) is for use only as the starting dose in patients with moderate renal impairment. Considering dose-dependent adverse reactions and the fact that pregabalin is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function. Dose adjustment in patients with renal impairment is based on creatinine clearance (CLcr) [Table 1]. [Table 1] Dosage of this medicine based on renal function Creatinine clearance (CLcr)* (mL/min) ≥60: Starting dose 150 (mg/day), maximum dose 600 (mg/day), once daily Creatinine clearance (CLcr)* (mL/min) ≥30-<60: Starting dose 75 (mg/day), maximum dose 300 (mg/day), once daily *Creatinine clearance (CLcr) can be estimated from serum creatinine (mg/dL) using the Cockcroft-Gault equation below. Creatinine clearance (mL/min)* = [140 – age (years)] x body weight (kg) / 72 x serum creatinine concentration (serum creatinine, mg/dL) *For women, multiply the result obtained from the above equation by 0.85. The safety and efficacy of this medicine have not been established in patients with severe renal impairment or end-stage renal disease with creatinine clearance (CLcr) less than 30 mL/min (see “11. Information for Healthcare Professionals,” “2) Pharmacokinetic Information” under “Precautions for Use”). 3. Patients with hepatic impairment The safety and efficacy of this medicine have not been established in patients with hepatic impairment. 5. Older adults (aged 65 years and older) The safety and efficacy of this medicine have not been established in older adults aged 65 years and older.
4. Pediatric and adolescent patients The safety and efficacy of this drug have not been established in pediatric and adolescent patients under 19 years of age.
This drug may increase the risk of suicidal thoughts or behaviors, so if mood or behavioral changes, symptoms of depression, etc., occur during treatment, consult a doctor immediately. Patients with hypersensitivity to this medication should not take it. Diabetes patients should be cautious as they may need to adjust their dose of blood sugar control medications due to weight gain. If allergic reactions such as angioedema occur, discontinue the medication immediately and inform medical personnel. Elderly patients should be particularly careful at the beginning of treatment due to risks of falls or injuries from dizziness or drowsiness. Visual changes such as blurred vision may occur, and such symptoms may improve after discontinuation of the medication. Withdrawal symptoms such as insomnia, headache, and anxiety may occur upon discontinuation, so the medication should be reduced gradually under a doctor's guidance. Due to the risk of drug abuse, patients with a history of substance abuse should be more cautious and report any abnormal behavior immediately. Patients with impaired kidney function may need dose adjustments. Patients with heart disease should be cautious as there may be a risk of congestive heart failure when taking this medication. Caution is advised if this drug is taken with opioid analgesics as it may increase central nervous system depressant effects, posing a risk of respiratory depression. It is best not to take the medication during pregnancy due to the risk of fetal malformation, and fertile women should use effective contraception. Women who are breastfeeding should discontinue nursing or consult a doctor while taking this medication as it may be passed into breast milk. Driving or operating dangerous machinery should be avoided until familiar with the effects of the drug, as dizziness and drowsiness may occur. In case of overdose, symptoms may include confusion, drowsiness, and seizures, and treatment such as hemodialysis may be necessary.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be kept in a tightly sealed container. Additionally, it is recommended to store the drug at room temperature, not too hot or too cold, ideally between 1°C and 30°C.
This medicine is a white to yellowish-brown, rectangular, film-coated, extended-release three-layer tablet.
30 tablets/box [(6 tablets/PTP x 5)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Pregabalin 42mg
Tablet · Prescription medication
GL Pharm Tech Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.